CharlesDavidWebbMD

PubMed

• Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
  Hainsworth, J. D.,Waterhouse, D. M.,Penley, W. C.,Shipley, D. L.,Thompson, D. S.,Webb, C. D.,Anthony Greco, F.> ;Cancer Invest.. 2013 Jun
• Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
  Spigel DR, Anthony Greco F, Waterhouse DM, Shipley DL, Zubkus JD, Bury MJ, Webb CD, Hart LL, Gian VG, Infante JR, Burris HA, Hainsworth JD> ;Lung Cancer. 2012-10-01
• A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer.
  Bendell JC, Meluch A, Peyton J, Rubin M, Waterhouse D, Webb C, Burris HA, Hainsworth JD> ;Clin Adv Hematol Oncol. 2012-07-01
• Sorafenib and everolimus (RAD001) in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase I/II trial.
  Waterhouse DM, Penley WC, Webb CD, Greco FA, Burris HA, Hainsworth JD> ;J. Clin. Oncol.. 2011-05-20
• Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.
  Spigel DR, Greco FA, Thompson DS, Webb C, Rubinsak J, Inhorn RC, Reeves J, Vazquez ER, Lane CM, Burris HA, Hainsworth JD> ;Clin Lung Cancer. 2010-05-01
• Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer.
  Yardley, D.A., Burris, H.A., Markus, T., Spigel, D.R., Greco, F.A., Mainwaring, M., Waterhouse, D.M., Webb, C.D., Hainsworth, J.D.> ;Clin Breast Cancer. 2009-11-01
• Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
  Infante JR, Yardley DA, Burris HA, Greco FA, Farley CP, Webb C, Spigel DR, Hainsworth JD> ;Clin. Breast Cancer. 2009-02-01
• Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients (pts) with HER2-positive metastatic breast cancer (MBC).
  Peacock NW, Infante JR, Yardley DA, Burris HA, Greco FA, Farley C, Webb C, Spigel DR, Hainsworth JD> ;J. Clin. Oncol.. 2008-05-20
• Phase II pilot results of imatinib mesylate with weekly docetaxel in metastatic breast cancer.
  Waterhouse DM, Mainwaring M, Barton J, Webb C, Markus TM, Spigel DR, Infante JR, Hainsworth JD, Greco FA, Yardley DA> ;J. Clin. Oncol.. 2008-05-20
• Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC).
  Rubinsak JR, Spigel DR, Hainsworth JD, Webb C, Inhorn RC, Infante JR, Yardley DA, Burris HA, Vazquez ER, Greco FA> ;J. Clin. Oncol.. 2008-05-20
• Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Netw...
  Greco, F.A., Spigel, D.R., Kuzur, M.E., Shipley, D., Gray, J.R., Thompson, D.S., Burris, H.A., Yardley, D.A., Pati, A., Webb, C.D., Gandhi, J.G., Hainsworth, J.D.> ;Clin Lung Cancer. 2007 Sep
• Paclitaxel, carboplatin, and gemcitabine (PCG) versus gemcitabine and vinorelbine (GV) in chemotherapy naïve patients (pts) with advanced non-small cell lung cancer (N...
  Kuzur ME, Shipley DL, Spigel DR, Gray JR, Thompson DS, Hainsworth JD, Bradof JE, Webb CD, Gandhi JG, Beschorner A, Greco FA> ;J. Clin. Oncol.. 2005-06-01
• First line treatment with weekly docetaxel, vinorelbine, and trastuzumab in HER2 overexpressing metastatic breast cancer (HER2+ MBC): A Minnie Pearl Cancer Research Ne...
  Yardley DA, Greco FA, Porter LL, Burris HA, Phelps C, Webb C, Schlabach L, Fichtel LM, Hainsworth JD> ;J. Clin. Oncol.. 2004-07-15
• Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
  Greco FA, Gray JR, Thompson DS, Burris HA, Erland JB, Barton JH, Litchy S, Houston GA, Butts JA, Webb C, Scott C, Hainsworth JD> ;Cancer. 2002-09-15
• Join now to see all